The meeting discussed mechanisms for localizing the
production of several pharmaceutical products in Egypt, which will be
manufactured domestically, as well as strategies for accessing African markets.
El-Ghamrawy emphasized the importance of supporting
pharmaceutical localization in Egypt, noting that this approach enhances
national health security and strengthens the export capabilities of Egyptian
products to regional and African markets.
He added that the EDA continually seeks to provide a
regulatory and legislative environment that incentivizes both local and
regional companies, ensuring the quality and safety of pharmaceutical products.
Dr. El-Ghamrawy also highlighted that cooperation between
the EDA and major pharmaceutical companies like SPIMACO represents a model of
successful partnerships, reflecting Egypt’s commitment to becoming a leading
regional hub for pharmaceutical manufacturing and exports.
The SPIMACO delegation praised the efforts of the Egyptian
Drug Authority in developing the pharmaceutical sector, affirming their
commitment to expanding cooperation with the authority in localization and
innovation, serving the needs of the local market and supporting the entry of
Egyptian products into African markets.
The SPIMACO delegation included Engineer Abdullah
Al-Rashidi, Chief Operations Officer and Plant Manager in Al Qassim; Dr. Hany
El-Husseiny, General Manager of SPIMACO Egypt; Muhannad bin Jamal, Executive
Director of Corporate Communications; and Dr. Norihan Mamdouh, Registration
Manager at SPIMACO Egypt.
From the Egyptian Drug Authority, attendees included Dr.
Hanan Amin, Head of the Central Administration for Pharmaceutical Products, and
Dr. Osama Hatem, Deputy Chairman of the Authority and Supervisor of the Central
Administration for Pharmaceutical Policies and Market Support.
The meeting underscores the Egyptian Drug Authority’s
commitment to supporting partnerships with regional and international
pharmaceutical companies and enhancing Egypt’s position as a regional center
for pharmaceutical manufacturing and exports.